Can the exacerbated synthesis of inflammatory markers in COVID-19 impair the response to treatments in patients with coronavirus?. Research, Society and Development, [S. l.], v. 11, n. 11, p. e337111133562, 2022. DOI: 10.33448/rsd-v11i11.33562. Disponível em: https://rsdjournal.org/rsd/article/view/33562. Acesso em: 5 dec. 2025.